|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salah S, Ahmad R, Sultan I, Yaser S and
Shehadeh A: Osteosarcoma with metastasis at initial diagnosis:
Current outcomes and prognostic factors in the context of a
comprehensive cancer center. Mol Clin Oncol. 2:811–816. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Subbiah V and Kurzrock R: Phase 1 clinical
trials for sarcomas: The cutting edge. Curr Opin Oncol. 23:352–360.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meng X, Wu J, Pan C, Wang H, Ying X, Zhou
Y, Yu H, Zuo Y, Pan Z, Liu RY and Huang W: Genetic and epigenetic
down-regulation of microRNA-212 promotes colorectal tumor
metastasis via dysregulation of MnSOD. Gastroenterology.
145:426–436, e421-e426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cekaite L, Rantala JK, Bruun J, Guriby M,
Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe
RA and Skotheim RI: miR-9, −31, and −182 deregulation promote
proliferation and tumor cell survival in colon cancer. Neoplasia.
14:868–879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schultz NA, Dehlendorff C, Jensen BV,
Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE,
Yilmaz M, Holländer NH, et al: MicroRNA biomarkers in whole blood
for detection of pancreatic cancer. JAMA. 311:392–404. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiang Y, Lu DL, Li JP, Yu CX, Zheng DL,
Huang X, Wang ZY, Hu P, Liao XH and Zhang TC: Myocardin inhibits
estrogen receptor alpha-mediated proliferation of human breast
cancer MCF-7 cells via regulating MicroRNA expression. IUBMB Life.
68:477–487. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Wang D, Xiong J, Chen L and Huang
J: MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is
downregulated in human osteosarcoma. Oncol Lett. 10:2135–2141.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai Y, Cai T and Chen Y: Wnt pathway in
osteosarcoma, from oncogenic to therapeutic. J Cell Biochem.
115:625–631. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mora-Blanco EL, Mishina Y, Tillman EJ, Cho
YJ, Thom CS, Pomeroy SL, Shao W and Roberts CW: Activation of
beta-catenin/TCF targets following loss of the tumor suppressor
SNF5. Oncogene. 33:933–938. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li YJ, Wei ZM, Meng YX and Ji XR:
Beta-catenin up-regulates the expression of cyclinD1, c-myc and
mmP-7 in human pancreatic cancer: Relationships with carcinogenesis
and metastasis. World J Gastroenterol. 11:2117–2123. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Trierweiler C, Blum HE and Hasselblatt P:
The transcription factor c-Jun protects against liver damage
following activated beta-catenin signaling. PLoS One. 7:e406382012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Muroya S, Taniguchi M, Shibata M, Oe M,
Ojima K, Nakajima I and Chikuni K: Profiling of differentially
expressed microRNA and the bioinformatic target gene analyses in
bovine fast- and slow-type muscles by massively parallel
sequencing. J Anim Sci. 91:90–103. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mao XH, Chen M, Wang Y, Cui PG, Liu SB and
Xu ZY: MicroRNA-21 regulates the ERK/NF-kappaB signaling pathway to
affect the proliferation, migration, and apoptosis of human
melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN. Mol
Carcinog. 56:886–894. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bing L, Hong C, Li-Xin S and Wei G:
MicroRNA-543 suppresses endometrial cancer oncogenicity via
targeting FAK and TWIST1 expression. Arch Gynecol Obstet.
290:533–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wickstrom M, Dyberg C, Milosevic J, Einvik
C, Calero R, Sveinbjörnsson B, Sandén E, Darabi A, Siesjö P, Kool
M, et al: Wnt/beta-catenin pathway regulates mgMT gene expression
in cancer and inhibition of Wnt signalling prevents
chemoresistance. Nat Commun. 6:89042015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ,
Lee KH, Yeh SD, Hong TM and Chen YL: MicroRNA-320 suppresses the
stem cell-like characteristics of prostate cancer cells by
downregulating the Wnt/beta-catenin signaling pathway.
Carcinogenesis. 34:530–538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma Y, Ren Y, Han EQ, Li H, Chen D, Jacobs
JJ, Gitelis S, O'Keefe RJ, Konttinen YT, Yin G and Li TF:
Inhibition of the Wnt-beta-catenin and Notch signaling pathways
sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res
Commun. 431:274–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Afanasyeva EA, Mestdagh P, Kumps C,
Vandesompele J, Ehemann V, Theissen J, Fischer M, Zapatka M, Brors
B, Savelyeva L, et al: MicroRNA miR-885-5p targets CDK2 and MCM5,
activates p53 and inhibits proliferation and survival. Cell Death
Differ. 18:974–984. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lam CS, Ng L, Chow AK, Wan TM, Yau S,
Cheng NS, Wong SK, Man JH, Lo OS, Foo DC, et al: Identification of
microRNA 885-5p as a novel regulator of tumor metastasis by
targeting CPEB2 in colorectal cancer. Oncotarget. 8:26858–26870.
2017. View Article : Google Scholar : PubMed/NCBI
|
